{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:13:05Z","timestamp":1788988385448,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtct.2026.04.020","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:56:35Z","timestamp":1781020595000},"page":"1082.e1-1082.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lnc-BRMS1L-4 and ZEB1-AS1 Expression in Acute Lymphoblastic Leukemia and Its Correlation With Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"32","author":[{"given":"Mahdiyar Iravani","family":"Saadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhroddin","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Noshadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani","family":"Ramzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahed","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ahmadyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Yaghobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.04.020_bib0001","doi-asserted-by":"crossref","DOI":"10.5812\/jjcmb.106563","article-title":"The association of apolipoprotein A1 gene polymorphisms with acute lymphocytic leukemia in Tehran province","volume":"11","author":"Bahrebar","year":"2020","journal-title":"Jentashapir J Cell Mol Biol"},{"key":"10.1016\/j.jtct.2026.04.020_bib0002","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s13337-021-00743-x","article-title":"MiR-181a and-b expression in acute lymphoblastic leukemia and its correlation with acute graft-versus-host disease after hematopoietic stem cell transplantation, COVID-19 and torque teno viruses","volume":"32","author":"Iravani Saadi","year":"2021","journal-title":"Virusdisease"},{"key":"10.1016\/j.jtct.2026.04.020_bib0003","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2017-04-778225","article-title":"Racial and ethnic disparities in hematologic malignancies","volume":"130","author":"Kirtane","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.04.020_bib0004","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199808273390907","article-title":"Acute lymphoblastic leukemia","volume":"339","author":"Pui","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2026.04.020_bib0005","doi-asserted-by":"crossref","first-page":"224","DOI":"10.34172\/aim.2021.34","article-title":"Geographical pathology of acute lymphoblastic leukemia in Iran with evaluation of incidence trends of this disease using joinpoint regression analysis","volume":"24","author":"Pordanjani","year":"2021","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.jtct.2026.04.020_bib0006","article-title":"Temporal trend and spatial distribution of acute lymphoblastic leukemia in Iranian children during 2006-2014: a mixed ecological study","volume":"42","author":"Pordanjani","year":"2020","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.jtct.2026.04.020_bib0007","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00018-017-2620-z","article-title":"Molecular processes involved in B cell acute lymphoblastic leukaemia","volume":"75","author":"Malouf","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jtct.2026.04.020_bib0008","doi-asserted-by":"crossref","unstructured":"Raetz, E.A., D.T. Teachey. T-cell acute lymphoblastic leukemia. Hematology 2014, the American Society of Hematology Education Program Book. 2016;2016:580\u2013588.","DOI":"10.1182\/asheducation-2016.1.580"},{"key":"10.1016\/j.jtct.2026.04.020_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087602","article-title":"Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein","volume":"9","author":"Diakos","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2026.04.020_bib0010","series-title":"TEL\/AML1 and E2A\/PBX1 Translocations Lead to Altered Folylpoly-\u03b3-Glutamate Synthetase (FPGS) Expression in ALL","author":"Barredo","year":"2005"},{"key":"10.1016\/j.jtct.2026.04.020_bib0011","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3892\/or.2016.4948","article-title":"Regulation of the miRNA expression by TEL\/AML1, BCR\/ABL, MLL\/AF4 and TCF3\/PBX1 oncoproteins in acute lymphoblastic leukemia","volume":"36","author":"Organista-Nava","year":"2016","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jtct.2026.04.020_bib0012","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.2147\/OTT.S115257","article-title":"E2A-PBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol","author":"Hu","year":"2016","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.jtct.2026.04.020_bib0013","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.2020005879","article-title":"Oncogenesis by E2A-PBX1 in ALL: RUNX and more","volume":"136","author":"Licht","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.04.020_bib0014","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/CCO.0b013e32834f5c41","article-title":"Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in adults","volume":"24","author":"Khaled","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jtct.2026.04.020_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1828223","article-title":"Hematopoietic stem cell transplantation for acute myeloid leukemia: an overview of systematic reviews","volume":"2022","author":"He","year":"2022","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jtct.2026.04.020_bib0016","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s12288-018-01066-6","article-title":"Aberrant expression of the miR-181b\/miR-222 after hematopoietic stem cell transplantation in patients with acute myeloid leukemia","volume":"35","author":"Iravani Saadi","year":"2019","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.020_bib0017","first-page":"1","article-title":"Characterization of MiR-92b, 1275 and 551 in patients with acute myeloid leukemia and their association with acute graft versus host disease after hematopoietic stem cell transplantation","volume":"6","author":"Saadi","year":"2020","journal-title":"Int J Hemat Ther"},{"key":"10.1016\/j.jtct.2026.04.020_bib0018","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1055\/s-0042-1742593","article-title":"Dysregulated expression of miR-19b, miR-25, miR-17, WT1, and CEBPA in patients with acute myeloid leukemia and association with graft versus host disease after hematopoietic stem cell transplantation","volume":"11","author":"Saadi","year":"2022","journal-title":"South Asian J Cancer"},{"key":"10.1016\/j.jtct.2026.04.020_bib0019","doi-asserted-by":"crossref","first-page":"26","DOI":"10.61186\/ijotm.2024.15.1148","article-title":"Investigating apoptotic effect through blocking miR-181b and miR-222 using LNA-anti-miRNA in HL-60 cell line: strategies to improve hematopoietic stem cell transplantation","volume":"15","author":"Saadi","year":"2024","journal-title":"Int J Organ Transplant Med"},{"key":"10.1016\/j.jtct.2026.04.020_bib0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11912-012-0247-7","article-title":"Philadelphia-positive acute lymphoblastic leukemia: current treatment options","volume":"14","author":"Liu-Dumlao","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jtct.2026.04.020_bib0021","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1158\/1541-7786.MCR-15-0006-T","article-title":"LncRNA expression discriminates karyotype and predicts survival in B-lymphoblastic leukemia","volume":"13","author":"Fernando","year":"2015","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jtct.2026.04.020_bib0022","doi-asserted-by":"crossref","first-page":"E11711","DOI":"10.1073\/pnas.1814397115","article-title":"Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases","volume":"115","author":"Li","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtct.2026.04.020_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104290","article-title":"Long noncoding RNA expression in acute lymphoblastic leukemia: A systematic review","volume":"196","author":"Lobo-Alves","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jtct.2026.04.020_bib0024","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11033-018-4447-6","article-title":"ARA lncRNA, is upregulated in liver and breast tumor tissues","volume":"46","author":"Raeisi","year":"2019","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.jtct.2026.04.020_bib0025","article-title":"The biological role of lncRNAs in the acute lymphocytic leukemia: An updated review","volume":"898","author":"Almanghadim","year":"2024","journal-title":"Gene"},{"key":"10.1016\/j.jtct.2026.04.020_bib0026","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.3390\/ijms23084442","article-title":"Linear and circular long non-coding RNAs in acute lymphoblastic leukemia: from pathogenesis to classification and treatment","volume":"23","author":"Maimaitiyiming","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtct.2026.04.020_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101870","article-title":"BRMS1L confers anticancer activity in non-small cell lung cancer by transcriptionally inducing a redox imbalance in the GPX2-ROS pathway","volume":"41","author":"Cao","year":"2024","journal-title":"Transl Oncol"},{"key":"10.1016\/j.jtct.2026.04.020_bib0028","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10555-020-09871-0","article-title":"BRMS1: a multifunctional signaling molecule in metastasis","volume":"39","author":"Zimmermann","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jtct.2026.04.020_bib0029","first-page":"62","article-title":"GVHD\u2014the nuts and bolts","volume":"2007","author":"Weisdorf","year":"2007","journal-title":"ASH Education Program Book"},{"key":"10.1016\/j.jtct.2026.04.020_bib0030","article-title":"Long noncoding RNA ZEB1-AS1 predicts an unfavorable prognosis of non-small lung cancer and regulates epithelial to mesenchymal transition through reducing ZEB1 expression","volume":"10","author":"Li","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jtct.2026.04.020_bib0031","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12423","article-title":"ZEB 1-AS 1: A crucial cancer-related long non-coding RNA","volume":"51","author":"Li","year":"2018","journal-title":"Cell Prolif"},{"key":"10.1016\/j.jtct.2026.04.020_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1102-6","article-title":"Long non-coding RNA ZEB1-AS1 regulates miR-200b\/FSCN1 signaling and enhances migration and invasion induced by TGF-\u03b21 in bladder cancer cells","volume":"38","author":"Gao","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jtct.2026.04.020_bib0033","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41419-019-1339-1","article-title":"lncRNA ZEB1-AS1 promotes pulmonary fibrosis through ZEB1-mediated epithelial\u2013mesenchymal transition by competitively binding miR-141-3p","volume":"10","author":"Qian","year":"2019","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.020_bib0034","first-page":"48","article-title":"Overexpression of long non-coding RNA ANRIL in B-acute lymphoblastic leukemia","volume":"11","author":"Bahraini","year":"2021","journal-title":"Iran J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtct.2026.04.020_bib0035","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s10529-017-2421-3","article-title":"LncRNA ZEB1-AS1 contributes to STAT3 activation by associating with IL-11 in B-lymphoblastic leukemia","volume":"39","author":"Wang","year":"2017","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.jtct.2026.04.020_bib0036","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2023-6552","article-title":"ZEB1-AS1 lncRNA prevents ZEB1 suppression and leads to tumor progression in undifferentiated AML subtype","volume":"83","author":"Percio","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtct.2026.04.020_bib0037","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3390\/cells10082051","article-title":"Hematopoietic dysfunction during graft-versus-host disease: a self-destructive process?","volume":"10","author":"M\u00fcskens","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jtct.2026.04.020_bib0038","article-title":"Long noncoding RNAs as emerging regulators of COVID-19","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2026.04.020_bib0039","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s13337-021-00743-x","article-title":"MiR-181a and -b expression in acute lymphoblastic leukemia and its correlation with acute graft-versus-host disease after hematopoietic stem cell transplantation, COVID-19 and torque teno viruses","volume":"32","author":"Iravani Saadi","year":"2021","journal-title":"Virusdisease"},{"key":"10.1016\/j.jtct.2026.04.020_bib0040","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/cncr.20668","article-title":"Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"101","author":"Kantarjian","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2026.04.020_bib0041","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2026.04.020_bib0042","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1172\/JCI66005","article-title":"Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity","volume":"124","author":"Velu","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2026.04.020_bib0043","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","article-title":"IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade","volume":"97","author":"Rowlings","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2026.04.020_bib0044","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s12288-018-01066-6","article-title":"Aberrant expression of the miR-181b\/miR-222 after hematopoietic stem cell transplantation in patients with acute myeloid leukemia","volume":"35","author":"Iravani Saadi","year":"2019","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.jtct.2026.04.020_bib0045","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.31661\/gmj.v10i0.2288","article-title":"Expression changes of CX3CL1 and interleukin-6 genes during remission induction therapy in patients with acute myeloid leukemia","volume":"10","author":"Vakil","year":"2021","journal-title":"Gal Med J"},{"key":"10.1016\/j.jtct.2026.04.020_bib0046","article-title":"Investigating apoptotic effect through blocking miR-181b and miR-222 using LNA-anti-miRNA in HL-60 cell line: strategies to improve hematopoietic stem","volume":"15","author":"Saadi","year":"2024","journal-title":"cell transplantation"},{"key":"10.1016\/j.jtct.2026.04.020_bib0047","doi-asserted-by":"crossref","first-page":"132","DOI":"10.15171\/jcvtr.2019.23","article-title":"The circulating level of interleukins 6 and 18 in ischemic and idiopathic dilated cardiomyopathy","volume":"11","author":"Saadi","year":"2019","journal-title":"J Cardiovasc Thorac Res"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.020_bib0048","first-page":"2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Euro Surv"},{"key":"10.1016\/j.jtct.2026.04.020_bib0049","article-title":"Positive reciprocal feedback of lncRNA ZEB1-AS1 and HIF-1 \u03b1 contributes to hypoxia-promoted tumorigenesis and metastasis of pancreatic cancer","volume":"11","author":"Jin","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtct.2026.04.020_bib0050","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1002\/jcb.29572","article-title":"ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA","volume":"121","author":"Luo","year":"2020","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jtct.2026.04.020_bib0051","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1111\/jcmm.16539","article-title":"ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN\/PI3K\/AKT signalling pathway by combining with P53","volume":"25","author":"Li","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jtct.2026.04.020_bib0052","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.yexcr.2018.08.013","article-title":"BRMS1L suppresses ovarian cancer metastasis via inhibition of the \u03b2-catenin-wnt pathway","volume":"371","author":"Cao","year":"2018","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jtct.2026.04.020_bib0053","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/bjc.2014.104","article-title":"Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer","volume":"110","author":"Balgkouranidou","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtct.2026.04.020_bib0054","doi-asserted-by":"crossref","first-page":"13966","DOI":"10.1002\/cam4.6027","article-title":"Long non-coding RNAs regulate treatment outcome in leukemia: What have we learnt recently?","volume":"12","author":"Shi","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.jtct.2026.04.020_bib0055","first-page":"287","article-title":"Research progress of long non-coding RNA in acute myeloid leukemia\u2013review","volume":"31","author":"Cun","year":"2023","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"key":"10.1016\/j.jtct.2026.04.020_bib0056","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2141.2011.08870.x","article-title":"Aberrant T-cell antigen expression in B lymphoblastic leukaemia","volume":"155","author":"Hussein","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2026.04.020_bib0057","first-page":"307","article-title":"Characteristics of fusion gene expression in acute lymphoblastic leukemia","volume":"51","author":"Huang","year":"2022","journal-title":"Zhonghua bing li xue za zhi"},{"key":"10.1016\/j.jtct.2026.04.020_bib0058","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40364-021-00303-x","article-title":"LncRNAs serve as novel biomarkers for diagnosis and prognosis of childhood ALL","volume":"9","author":"Huang","year":"2021","journal-title":"Biomark Res"},{"key":"10.1016\/j.jtct.2026.04.020_bib0059","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.7150\/jca.25264","article-title":"The significant prognostic value of ZEB1-AS1 up-regulation in patients with cancer","volume":"9","author":"Ni","year":"2018","journal-title":"J Cancer"},{"key":"10.1016\/j.jtct.2026.04.020_bib0060","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.7150\/jca.27263","article-title":"The prognostic value of long noncoding RNA ZEB1-AS1 on clinical outcomes in human cancer","volume":"9","author":"Wu","year":"2018","journal-title":"J Cancer"},{"key":"10.1016\/j.jtct.2026.04.020_bib0061","article-title":"A review on the role of ZEB1-AS1 in human disorders","volume":"245","author":"Ghafouri-Fard","year":"2023","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.jtct.2026.04.020_bib0062","doi-asserted-by":"crossref","DOI":"10.5812\/zjrms.10197","article-title":"The frequency of BCR-ABL1 fusion transcripts in Iranian patients with three different types of leukemia","volume":"19","author":"Hamid","year":"2017","journal-title":"Zahedan J Res Med Sci"},{"key":"10.1016\/j.jtct.2026.04.020_bib0063","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.7150\/jca.42093","article-title":"Aberrant LncRNA expression in leukemia","volume":"11","author":"Gao","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.jtct.2026.04.020_bib0064","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.12943","article-title":"Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors","volume":"7","author":"Byrgazov","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtct.2026.04.020_bib0065","doi-asserted-by":"crossref","DOI":"10.21608\/smj.2017.41399","article-title":"Philadelphia chromosome in acute lymphoblastic leukemia","volume":"21","author":"Fouad","year":"2017","journal-title":"Sohag Med J"},{"key":"10.1016\/j.jtct.2026.04.020_bib0066","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.jtct.2023.12.170","article-title":"Philadelphia-like B-cell acute lymphoblastic leukemia in a largely Hispanic population: disease features and outcomes in the era of immunotherapy a single institutional study","volume":"30","author":"Hom","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.04.020_bib0067","doi-asserted-by":"crossref","DOI":"10.1177\/03000605231156757","article-title":"Philadelphia chromosome-positive T-cell acute lymphoblastic leukemia: a case report","volume":"52","author":"Dong","year":"2024","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jtct.2026.04.020_bib0068","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3324\/haematol.2018.196055","article-title":"Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"104","author":"Fedullo","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2026.04.020_bib0069","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.586567","article-title":"Multi-lineage BCR-ABL expression in Philadelphia chromosome-positive acute lymphoblastic leukemia is associated with improved prognosis but no specific molecular features","volume":"10","author":"Nishiwaki","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtct.2026.04.020_bib0070","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1002\/cncr.25978","article-title":"Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors","volume":"117","author":"Jaso","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2026.04.020_bib0071","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41392-020-00457-4","article-title":"Longitudinal transcriptome analyses show robust T cell immunity during recovery from COVID-19","volume":"5","author":"Zheng","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jtct.2026.04.020_bib0072","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/pathogens13121070","article-title":"Equivocating and deliberating on the probability of COVID-19 infection serving as a risk factor for lung cancer and common molecular pathways serving as a link","volume":"13","author":"Amara","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.jtct.2026.04.020_bib0073","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s43046-023-00174-3","article-title":"miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options","volume":"35","author":"Saadi","year":"2023","journal-title":"J Egypt Natl Canc Inst"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726003052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726003052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:51:51Z","timestamp":1788987111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726003052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666636726003052"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.04.020","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lnc-BRMS1L-4 and ZEB1-AS1 Expression in Acute Lymphoblastic Leukemia and Its Correlation With Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}